A Novel Coronavirus Disease (COVID-19) : a Review of Host Cell Signaling Pathways
Copyright© 2020 National Research Institute of Tuberculosis and Lung Disease..
Coronaviruses (CoVs) are the largest group of positive-sense RNA viruses. By increasing our understanding of the interactions between CoVs and the host innate immune system, we can evaluate the development and persistence of inflammation in the lungs and reduce the risk of CoV-induced lung inflammation with a new group of genetic variants. Here, we aim to discuss some recent changes in host cell factors that may be used by CoV to promote the proliferation cycle. We also discuss different host cell signaling pathways that can be considered in the host-pathogen interactions at the molecular level. The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created new challenges for the cultural, economic, and health infrastructures. Therefore, it is important that healthcare systems and physicians recognize a global integrated framework for monitoring the progression of COVID-19 to develop targeted therapies that can potentially save human lives.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Tanaffos - 19(2020), 2 vom: 18. Nov., Seite 108-111 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mohammadpour, Hadiseh [VerfasserIn] |
|---|
| Themen: |
Coronavirus |
|---|
| Anmerkungen: |
Date Revised 30.03.2024 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM318290227 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318290227 | ||
| 003 | DE-627 | ||
| 005 | 20240330234151.0 | ||
| 007 | tu | ||
| 008 | 231225s2020 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1356.xml |
| 035 | |a (DE-627)NLM318290227 | ||
| 035 | |a (NLM)33262797 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mohammadpour, Hadiseh |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Novel Coronavirus Disease (COVID-19) |b a Review of Host Cell Signaling Pathways |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Revised 30.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright© 2020 National Research Institute of Tuberculosis and Lung Disease. | ||
| 520 | |a Coronaviruses (CoVs) are the largest group of positive-sense RNA viruses. By increasing our understanding of the interactions between CoVs and the host innate immune system, we can evaluate the development and persistence of inflammation in the lungs and reduce the risk of CoV-induced lung inflammation with a new group of genetic variants. Here, we aim to discuss some recent changes in host cell factors that may be used by CoV to promote the proliferation cycle. We also discuss different host cell signaling pathways that can be considered in the host-pathogen interactions at the molecular level. The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created new challenges for the cultural, economic, and health infrastructures. Therefore, it is important that healthcare systems and physicians recognize a global integrated framework for monitoring the progression of COVID-19 to develop targeted therapies that can potentially save human lives | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a Host-pathogen interactions | |
| 650 | 4 | |a Signaling pathways | |
| 700 | 1 | |a Ziai, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Sadr, Makan |e verfasserin |4 aut | |
| 700 | 1 | |a Rezaei, Mitra |e verfasserin |4 aut | |
| 700 | 1 | |a Marjani, Majid |e verfasserin |4 aut | |
| 700 | 1 | |a Tabarsi, Payam |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Tanaffos |d 2011 |g 19(2020), 2 vom: 18. Nov., Seite 108-111 |w (DE-627)NLM24161676X |x 1735-0344 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2020 |g number:2 |g day:18 |g month:11 |g pages:108-111 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2020 |e 2 |b 18 |c 11 |h 108-111 | ||